Security Snapshot

TRINITY BIOTECH PLC - @Class 'A' Ordinary Shares represented by American Depositary Shares (TRIB) Institutional Ownership

CUSIP: 896438306

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2024

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Shares outstanding
18,697,629
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • TRIB - TRINITY BIOTECH PLC - @Class 'A' Ordinary Shares represented by American Depositary Shares is tracked under CUSIP 896438306.
  • Latest finished 13F holder period is not available.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 25 to 0 between Q4 2023 and Q1 2024.
  • SEC-reported value moved from $2,583,427 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

896438306

Latest holder period

n/a

13F holders

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
TRIB
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MiCo IVD Holdings, LLC 18% $31,252,824 69,450,720 MiCo IVD Holdings, LLC 17 Dec 2024
Novus Diagnostics Ltd. 6% 1,119,988 Novus Diagnostics Ltd. 23 Dec 2025

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
41
Latest
n/a
Rows shown
1-25 of 41
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q1 0 $0 -$2,570,471 0
2023 Q4 6,017,301 $2,583,427 -$60,379 $0.43 25
2023 Q3 6,136,275 $4,492,942 -$57,991 $0.74 20
2023 Q2 6,203,359 $5,927,524 -$120,184 $0.95 20
2023 Q1 6,322,223 $5,960,890 -$246,043 $0.94 20
2022 Q4 6,575,585 $6,511,053 -$453,316 $0.99 20
2022 Q3 7,013,813 $7,494,454 -$301,117 $1.07 18
2022 Q2 7,293,307 $8,921,000 -$1,903,060 $1.22 17
2022 Q1 9,017,002 $9,558,000 +$3,817,525 $1.06 18
2021 Q4 5,387,370 $7,700,000 -$285,833 $1.43 17
2021 Q3 5,515,826 $11,909,000 -$396,530 $2.16 20
2021 Q2 5,663,570 $16,647,000 +$630,861 $2.94 26
2021 Q1 5,404,173 $20,322,000 -$2,001,163 $3.76 31
2020 Q4 5,935,793 $22,614,000 -$313,125 $3.81 22
2020 Q3 6,300,475 $12,723,000 -$2,024,499 $2.02 21
2020 Q2 7,280,574 $15,872,000 -$1,212,557 $2.18 24
2020 Q1 8,778,536 $9,657,000 -$1,744,161 $1.10 20
2019 Q4 10,421,414 $10,760,000 -$896,842 $1.03 23
2019 Q3 10,629,465 $12,858,000 -$2,017,166 $1.21 24
2019 Q2 11,817,237 $20,196,000 -$4,061,095 $1.65 30
2019 Q1 13,086,618 $37,292,000 -$263,164 $2.85 35
2018 Q4 13,207,308 $30,239,000 -$4,288,060 $2.29 35
2018 Q3 14,301,903 $57,202,000 -$1,180,790 $4.00 43
2018 Q2 14,578,989 $72,890,000 -$3,282,605 $5.00 42
2018 Q1 15,232,918 $78,447,079 +$1,820,197 $5.15 44
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .